The prognostic impact of tumour infiltrating lymphocytes (TILs) has been reported in various organs, including the breast, and specifically in human epidermal growth factor receptor 2 (HER2)-positive and triple-negative breast cancers (TNBCs)16. Here, ERBB2 is linked to triple-negative breast carcinoma.